APOLLOMICS INC-27 (APLMW)

0.009  0 (-3.23%)

APOLLOMICS INC-27

NASDAQ:APLMW (1/3/2025, 8:20:09 PM)

0.009

0 (-3.23%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorN/A
GICS IndustryN/A
GICS SubIndustryN/A
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
CRS3.47
6 Month-42.31%
Overview
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Ins OwnersN/A
Inst OwnersN/A
Market Cap0
SharesN/A
PEN/A
Fwd PEN/A
Dividend YieldN/A
AnalystsN/A
Short Float %N/A
Short Ratio0.63
IPON/A N/A
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

APLMW Daily chart

APLMW News

ChartMill News Image2 days ago - ChartmillThe market is buzzing with gapping stocks on Friday. Let's uncover which stocks are experiencing notable gaps during today's session.

Traders are paying attention to the gapping stocks in Friday's session. Let's dive into which stocks are experiencing notable gaps.

ChartMill News Image10 days ago - ChartmillWhat's going on in today's session

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

News Image16 days ago - Apollomics Inc.Apollomics 公布在中国对复发或难治性急性髓系白血病患者进行的 Uproleselan III 期桥接试验主要结果

加利福尼亚州福斯特城, Dec. 21, 2024 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) (简称 “Apollomics” 或 “公司”)...

News Image16 days ago - Apollomics Inc.Apollomics 公布 Uproleselan 在中國治療復發或難治性急性髓系白血病患者的第 3 期銜接性試驗的主要結果

福特斯城，加州, Dec. 21, 2024 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) (「Apollomics」或「該公司」) 是一家後期臨床生物製藥公司，開發多種腫瘤候選藥物以解決難治性和對治療有抗藥性的癌症。該公司今日公布了其藥物...

News Image16 days ago - Apollomics Inc.Apollomics Announces Top-line Results for Phase 3 Bridging Trial of Uproleselan in China in Patients with Relapsed or Refractory Acute Myeloid Leukemia

FOSTER CITY, Calif., Dec. 20, 2024 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) (“Apollomics” or the “Company”), a late-stage clinical...

News Image26 days ago - Apollomics Inc.Apollomics Regains Compliance with Nasdaq’s Minimum Bid Price Requirement

APLMW Twits

Here you can normally see the latest stock twits on APLMW, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example